Titan Pharmaceuticals Inc (TTNP)
6.82
0.00 (0.00%)
USD |
NASDAQ |
May 09, 16:00
6.82
0.00 (0.00%)
After-Hours: 20:00
Titan Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.001M |
| March 31, 2023 | |
| December 31, 2022 | 0.051M |
| September 30, 2022 | 0.004M |
| June 30, 2022 | 0.003M |
| March 31, 2022 | 0.003M |
| December 31, 2021 | 0.004M |
| September 30, 2021 | 0.04M |
| June 30, 2021 | 0.445M |
| March 31, 2021 | 0.682M |
| December 31, 2020 | 1.445M |
| September 30, 2020 | 1.018M |
| June 30, 2020 | 1.249M |
| March 31, 2020 | 1.126M |
| December 31, 2019 | 0.211M |
| September 30, 2019 | 0.947M |
| June 30, 2019 | 0.502M |
| March 31, 2019 | 0.945M |
| December 31, 2018 | 1.237M |
| September 30, 2018 | 1.65M |
| June 30, 2018 | 2.668M |
| March 31, 2018 | 1.064M |
| December 31, 2017 | 0.058M |
| September 30, 2017 | 0.04M |
| June 30, 2017 | 0.077M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.04M |
| December 31, 2016 | 0.035M |
| September 30, 2016 | 0.026M |
| June 30, 2016 | 15.00M |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.76M |
| March 31, 2015 | 0.911M |
| December 31, 2014 | 0.912M |
| September 30, 2014 | 0.911M |
| June 30, 2014 | 0.911M |
| March 31, 2014 | 0.911M |
| December 31, 2013 | 0.911M |
| September 30, 2013 | 2.198M |
| June 30, 2013 | 2.198M |
| March 31, 2013 | 5.174M |
| December 31, 2012 | 3.259M |
| September 30, 2012 | 1.228M |
| June 30, 2012 | 1.36M |
| March 31, 2012 | 1.27M |
| December 31, 2011 | 1.413M |
| September 30, 2011 | 1.012M |
| June 30, 2011 | 0.695M |
| March 31, 2011 | 0.948M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.001M
Minimum
Jun 2023
1.445M
Maximum
Dec 2020
0.4832M
Average
0.328M
Median
Revenue (Quarterly) Benchmarks
| Outset Medical Inc | 30.51M |
| Allurion Technologies Inc | 8.235M |
| AIM ImmunoTech Inc | 0.065M |
| Protalix BioTherapeutics Inc | 10.49M |
| Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.97M |
| Total Expenses (Quarterly) | 1.931M |
| EPS Diluted (Quarterly) | -2.61 |
| Enterprise Value | -0.0242M |
| Earnings Yield | -108.7% |
| Normalized Earnings Yield | -167.01 |